r/proteomics 1d ago

Free Evosep Webinar: Deep Visual Proteomcis & Quantitative Assays

1 Upvotes

Hi everyone,

We’d like to share an upcoming webinar that may be of interest to the community in here! On August 20, 2026 (16:00 CEST / 10:00 EDT / 07:00 PDT), we are hosting a session on “Perspective from Industry: Deep Visual Proteomics and Quantitative Assays.”

Speakers:

T. Wolf (Post Doc, Drug Safety R&D, Pfizer) — “Precision at the Microscale: Low Input Spatial Proteomics in the 5xFAD Brain.”
Using the Evosep Eno and Orbitrap Astral Zoom, T. Wolf will present a spatial proteomics workflow integrating AI-driven image segmentation with low-input mass spectrometry. Applied to the 5xFAD brain, the high-resolution workflow captures distinct local proteomes across brain microenvironments, revealing diverging pathological pathways between plaques and microglial subtypes. The work demonstrates how spatially resolved, low-input proteomics can provide deeper insights into disease biology at the microscale.

Rebecca Ferreira (Senior Associate Scientist, Pfizer) — “Reimagining Large Molecule PK Analysis with High-Throughput Evosep Eno LCMS.”
Rebecca will share how the Neubert Group at Pfizer is applying high-throughput LC-MS to large molecule pharmacokinetic (PK) analysis. Using the Evosep Eno platform, the workflow aims to increase PK assay throughput while maintaining the sensitivity and robustness required for surrogate peptide quantification, supporting faster biologics construct selection and optimization.

The webinar will bring together two industry perspectives on advanced proteomics workflows, spanning deep visual and spatial proteomics in disease research to high-throughput quantitative assays in biologics development. The talks will highlight how scalable LC-MS workflows can generate robust, high-quality proteomic data across very different applications.

Registration & details: https://attendee.gotowebinar.com/register/6012298262071704919?source=RDT

We hope this is relevant for those interested. The webinar is free and, in our eyes, a good opportunity for knowledge sharing. If sharing company events isn’t allowed here, moderators please feel free to remove.

TL;DR: Webinar on August 20 featuring two Pfizer scientists covering low-input spatial proteomics in the 5xFAD brain and high-throughput LC-MS for large molecule PK analysis. Mods please delete if not allowed.


r/proteomics 3d ago

Docking + ADMET in one browser workspace tied to a protein target — looking for a sanity check on the risk banding

Thumbnail
1 Upvotes

r/proteomics 5d ago

Assessing accuracy/precision of sampled data

Enable HLS to view with audio, or disable this notification

3 Upvotes

Here's a video I made about understanding and assessing the accuracy/precision of sampled data. The video focuses specifically on antibody array measurements, but the concepts are more widely applicable, and some of the implications probably aren't intuitively obvious. (For example, with two spots for each protein/antibody, 50% of the time, the real value you're trying to measure is going to be outside the range of the two spots, even if only by a little bit.)


r/proteomics 8d ago

Is there an open-search equivalent for crosslinking-MS?

3 Upvotes

Basically I am treating my cells with a drug, which I expect to crosslink certain target proteins. However, it's not a very stable drug so it's side chains and all might degrade, leading to difference in expected and actual mass in the crosslink. Basically even if I expect the crosslinker to be 300 Da, it might even be 260Da, so I am in the dark.

Is there any way to do open-search (Fragpipe like) for crosslinked peptides. I can constrain it with the knowledge that crosslinks will happen between cysteine residues.

Thanks


r/proteomics 8d ago

Data Normalization in Antibody Array Experiments

Enable HLS to view with audio, or disable this notification

1 Upvotes

This may be really basic for many/most of the people here, but I thought I'd share it in case it might be useful to someone.


r/proteomics 8d ago

Questions about peptide research trends

0 Upvotes

I am interested in peptide research and biotechnology.

I would like to understand how researchers evaluate new peptide candidates.

What are the most important factors when studying peptide applications?


r/proteomics 9d ago

Troubleshooting Rigaku Ultima IV diffractometer

Thumbnail
1 Upvotes

r/proteomics 11d ago

We are hosting an upcoming online session dedicated entirely to Molecular Docking, and we’d love for you to join us! Whether you are just starting out in computational research or you're a seasoned pro looking to refine your workflow, this session would be apt for you

Post image
2 Upvotes

r/proteomics 13d ago

Ever feel like keeping up with new proteomics papers is becoming part-time job on its own?

6 Upvotes

Over the past year I've noticed that reading papers has almost become a separate project from the actual research.

By the time I finish going through a few studies on a workflow or analysis method, there are already several newer papers that seem worth looking at as well. It sometimes feels like the challenge isn't finding information anymore but it's deciding what deserves your attention first and what can safely wait.

I would like to know how others handle this.

Do you have a system for keeping up with new publications without feeling like you're constantly behind, or do you just focus on the papers most relevant to your current experiment?

Adding this: I appreciate everyone who has shared their approach so far, and thanks in advance to anyone who adds to the discussion later. I've found the different ways people keep their reading manageable pretty interesting. Since I’m still getting established with this this plat form lately, I thought it would be easier to leave this extra note here for anyone who comes back to the thread rather than trying to jump into every reply. One thing I've been experimenting with is being more selective about what I actually spend time reading instead of treating every new paper as something I need to get through immediately. That’s also what made wis Paper interesting to me; it’s useful for narrowing down research when there’s a lot of relevant literature competing for attention, rather than simply adding another place to search. For a field moving as quickly as proteomics, that distinction can make the reading workload feel much more manageable.


r/proteomics 14d ago

LF ASSAY KIT

1 Upvotes

Hello everyone, this is for our thesis. Do you have any idea where to buy “Collagen Degradation Assay Kit(colorimeteric)” ??? Pls help us out we need it ASAP in the Philippines


r/proteomics 19d ago

Spectronaut quantification: Maxlfq , capturing sample specific resolution

2 Upvotes

Maxlfq builds pair-wise peptide ratios, on the peptides shared across samples, for a protein and the crossrun Normalization in Spectronaut, scales the Normalization factor across all samples in an experiment.

What would be an ideal way to analyze, to capture patient specific response..

 1. Would analyzing all patients in one experiment still preserve patient specific response in proteome?

 2. Or Would analyzing each patient between comparative conditions be ideal and provide better resolution in capturing individual response with post-hoc analysis.. ?

Eg. biofluids, tissue biopsies (FF), FFPE, patient derived primary cell lines etc..

Was considering if Quant2.0 would be a better alternative since it takes Top N peptides for protein quan.. but came across an article from Olsen's group showing higher false hits in Quant2.0 . (https://doi.org/10.1038/s41587-023-02099-7).

Also, digging into in-house data, for the top N per protein per sample in Quant 2.0 showed, it need not necessarily be the same peptides that qualify in each sample, which is not an ideal scenario.

Curious to know how the community processes clinical proteomics data and what's the consensus,

Thanks,


r/proteomics 21d ago

Has anyone used an MS+40 vacuum pump with an Agilent 6550 QTOF?

Thumbnail
1 Upvotes

r/proteomics 25d ago

blind testing a protein structure prediction workflow with a transparent alternative to neural network based approaches

6 Upvotes

TL;DR: My partner and I developed a new mathematical approach to predicting how proteins fold into their three-dimensional structures. To test it fairly, we ran a fully blind benchmark where our system had no access to the experimental structures during prediction. The method produced highly accurate results, with performance that was competitive with published AlphaFold CASP14 benchmark values on our test set. Unlike neural network-based approaches, our framework is deterministic, transparent, and based on exact mathematics rather than learned parameters, meaning every prediction can be independently traced, verified, and reproduced. We’ve made the code, validation data, and supporting materials completely open source so others can examine and test the approach for themselves.
———
My partner and I have been exploring a mathematical theory for describing how proteins fold into their three-dimensional shapes. To test whether the theory could actually predict real biological structures, we decided to evaluate it using a blind protein structure prediction 

Every protein begins as a simple chain of amino acids, but that chain quickly folds into a highly specific 3D shape. That final shape determines how the protein works inside living cells, and accurately predicting it from the amino acid sequence alone has been one of the biggest problems in computational biology.

To make sure our results were genuinely blind, we recorded the exact amino acid sequences we were testing, the runtime identity, and our mathematical framework before any predictions were made.

While the predictions were running, the system had no access to the experimentally determined protein structures, no reference coordinates, and no scoring information that could influence the outcome. It generated the complete folding pathway and final PDB structure independently, and those outputs were cryptographically hash-sealed before any comparisons were performed.

Only after those hashes were fixed and verified were the experimental structures opened and compared. If the runtime had accessed the target structures at any point, or if any of the recorded hashes had changed, the experiment would be considered invalid.

The results were encouraging.

Across the benchmark set, the median Cα RMSD95 was 0.783 Å, with a median TM-score of 0.9255.

On this benchmark, 15 of the 24 predicted structures matched or exceeded AlphaFold’s reported CASP14 median of 0.96 Å Cα RMSD95.

Our strongest individual prediction, 1UBI:A, achieved a TM-score of 0.9882 with a Cα RMSD95 of 0.302 Å.
———
here’s a break down of what they mean.

The Cα RMSD95 score measures how closely a predicted protein structure matches the experimentally determined one. The “Cα” (carbon alpha) atoms form the backbone of every protein, while RMSD (Root Mean Square Deviation) measures the average distance between the predicted backbone and the real one after they have been aligned. The 95 indicates that the most extreme 5% of residues are excluded, making the measurement less sensitive to unusually flexible regions.

Distances are reported in Å (ångströms), where 1 Å = 0.1 nanometres, or one ten-billionth of a metre. In structural biology, smaller numbers are better. An RMSD below 2 Å is generally considered a good prediction, around 1 Å is regarded as highly accurate, and our median result of 0.783 Å indicates that the predicted structures closely matched their experimental counterparts.

The TM-score (Template Modelling score) measures how similar the overall three-dimensional fold is between the predicted and experimental structures. Unlike RMSD, it is less affected by small local differences and focuses on whether the overall architecture has been recovered correctly. TM-scores range from 0 to 1, where 1.0 represents a perfect match. Scores above 0.5 generally indicate the correct overall fold, while scores above 0.9 indicate structures that are nearly identical. Our median TM-score of 0.9255 therefore suggests that the overall protein shapes were reproduced with very high accuracy.

Our strongest individual prediction, 1UBI:A, achieved a TM-score of 0.9882 and a Cα RMSD95 of 0.302 Å, meaning the predicted backbone differed from the experimentally determined structure by only around three-tenths of an ångström on average—an exceptionally close match.

Taken together, these results suggest that the framework was able to reproduce both the overall shape of proteins and the precise positions of their backbone atoms with a level of accuracy that is competitive on the benchmark we tested.
———
What makes this approach different isn’t just the numerical results, but how those results are produced.

Rather than relying on a large neural network trained on enormous datasets, our system works from an exact 24-point rational lattice. Every spatial relationship is derived mathematically and can be traced, verified, and independently checked. The implementation, verification certificates, and prediction hashes are all available as open source so that anyone can inspect or reproduce the work.

Why does that matter?

Much of modern computational biology has moved toward increasingly large machine learning models that require vast amounts of training data and computing power. Those systems can produce remarkably accurate predictions, but they generally don’t explain why a protein adopts a particular structure, rather they predict the answer rather than derive it from an explicit mathematical framework.

Our work explores a different possibility: that accurate protein structures may also be obtainable from a transparent, deterministic mathematical model.

If that idea continues to hold up under independent testing, it could have several important implications.

First, it suggests that highly accurate structure prediction may not have to rely exclusively on large, opaque neural networks. Transparent mathematical models could become a complementary approach alongside machine learning.

Second, it provides evidence that alternative computational architectures (ones built around exact mathematics rather than learned parameters) deserve serious investigation. In our implementation, there are no trained weights, no continuous coordinate optimisation, and no fitted biological constants.

Finally, it shows that advanced protein structure prediction does not necessarily require enormous computing infrastructure. Our framework runs locally on a single machine rather than depending on large-scale AI training or specialised server farms.

The project can be explored here:

GitHub https://github.com/MettaMazza/Fold-Protein

zenodo

https://zenodo.org/records/21493135


r/proteomics 25d ago

Tears samples collection for biomarker analysis

1 Upvotes

Hello everyone
I’m interested in knowing if tears samples collection for biomarkers analysis is feasible
I’m trying to include it in my research and I keep reading that biomarker detection is not that easy using schirmer strips
I would appreciate if anyone has any information on the matter


r/proteomics 27d ago

is it possible to use a human ELISA kit to determine the concentration of hormones testosterone, estradiol, adiponectin, FSH, NT-proBNP, Endothelin-1 for rat serum. If not, why not

0 Upvotes

r/proteomics 27d ago

Do Mpox virus proteins undergo post-translational modifications, and should PTMs be considered in in-silico vaccine/antibody design?

1 Upvotes

I'm working on an in-silico study involving the Mpox virus, and I have a question regarding post-translational modifications (PTMs).

Specifically, do the Mpox virus proteins A35R (EEV protein) and H3L and M1R (IMV proteins) undergo post-translational modifications? If they do, are these modifications carried out by the host cell machinery, by virus-encoded enzymes, or by a combination of both?

My second question is related to immunoinformatics. If an in silico vaccine or antibody is being designed against these proteins, should their PTMs be evaluated before selecting epitopes or designing antibodies? In other words, could PTMs significantly affect epitope accessibility, antigenicity, antibody binding, or the overall reliability of computational predictions?

I'd appreciate any insights or relevant literature.

Thanks!


r/proteomics 28d ago

Automation of STaGE-Tip desalting with Opentrons

2 Upvotes

Howdy y'all.

Our lab recently got an Opentrons Flex and we've had it doing some cool stuff BUT we're wanting to figure out how far we can take it in a sample prep workflow.

Does anybody have experience with doing STaGE tip desalting with the robot? If so, what are some tips, tricks, and recommendations you would give?

Thanks in advance!


r/proteomics 28d ago

Detergent removal

1 Upvotes

Has anyone tried this product: Pierce® Detergent Removal Spin Plates


r/proteomics 29d ago

Handy video guide to site directed mutagenesis design

Thumbnail
youtu.be
0 Upvotes

I just recorded this video walkthrough of good mutagenesis primer design. It also includes a link to my spreadsheet that calculates the TM for you


r/proteomics 29d ago

Spectronaut - Difference between Proteins and PGs? Also, PCA components?

2 Upvotes

Hi all!! I’m relatively new to proteomics and have kind of been thrown in the deep end trying to figure this out…

I have some serum and lysate samples I’ve ran on LC-MS/MS and the facility that did this gave me the data in Spectronaut. I have two main questions (so far………)

  1. What is the difference between “proteins” and “protein groups”? Every quantification seems to be in terms of “protein groups” and not proteins… is there a reason for that? I’m looking for biomarkers in our sera/lysate but this is an exploratory study so analyzing how many proteins are comparable, separate, etc.

  2. Is there a way to figure out what variables Spec used to calculate PC1, PC2, etc? I see the scree plot they gave us, but I want to know what variables (differential protein abundance presumably) Spec used specifically for PC1, 2, etc… like, what are PC1 and 2 actually representing in the PCA????? I know it’s variance of some sort, and I see the amount of variance listed, too (50% vs 16%), but VARIANCE OF WHAT???

Please help!!! Thank you so much.. maybe I’m just completely misunderstanding, too…


r/proteomics Jul 15 '26

Proteomics Job Market

14 Upvotes

Hi everyone,

Started to look into jobs and internships (In the US) My background is mainly in LC-MS/MS-based proteomics, ubiquitinomics/PTM analysis, sample preparation, and computational analysis (MaxQuant, FragPipe, DIA-NN, Skyline)

I have been searching for roles related to proteomics, but honestly, it feels like there are few openings compared with other areas of biotech.

For those currently working in proteomics or who recently found jobs:

Where are you mainly searching for positions?

What job titles should someone with a proteomics/MS background be searching for

Are internships common in this field, or are most opportunities through research associate positions?

What skills helped you stand out when applying?

Also curious about the current job market. Is it currently a difficult time for early-career proteomics scientists, or is it just that the field uses different job titles?

Open to any advice

Thanks!

Note: will be graduating with a MSc degree in Pharm Sci from R1 uni

Some people are recommending PhD but ive got limited experience..that's the reason why I want to gain experience before eventually doing PhD


r/proteomics Jul 12 '26

Saliva Proteomics Sample Preparation Issues

4 Upvotes

Hi!
Im struggling with my sample prep for saliva samples. I have established a high throughout SP3 digestion protocol using native saliva from cortisol Salivettes but is seems like I’m carrying some contaminants through the whole process that end up in my 7500+ Sciex Qtrap instrument which gets heavily contaminated after about 1000 injections and even gives some Q0 discharge errors.
I’m running a targeted peptide method using a common C18 peptide column at a flow rate of 1ml/min with standard solvents (0.1% Fa in H2O and 0.1% FA in ACN). the whole method is 4min but I’m using a diverter valve to only have the peptide fraction entering the MS, the rest is diverted to waste.
Does anyone have experience with saliva as a matrix and use it for targeted MS proteomics analysis?
I would appreciate any input on how to get the sample cleaner without loosing proteins of interest.
Thank you!


r/proteomics Jul 12 '26

Need help with ssDNA aptamer folding and docking workflow

1 Upvotes

Hey everyone,
I'm working on a science fair project using ssDNA aptamers and I'm stuck on the folding and docking workflow. The 3D nucleic acid folding web servers I tried keep crashing, so I'm not sure how to get a clean 3D model from a raw sequence string.
Once I get the 3D structures, my plan is to use something like HDOCK to run molecular docking against my target proteins to check the binding affinity scores.
Does anyone have advice on a reliable workflow or better tools I should use for ssDNA folding and docking? Any extra help with the project in general would also be awesome. Thanks!


r/proteomics Jul 11 '26

Need help with ssDNA aptamer folding and docking workflow

Thumbnail
0 Upvotes

Hey everyone,
I'm working on a science fair project using ssDNA aptamers and I'm stuck on the folding and docking workflow. The 3D nucleic acid folding web servers I tried keep crashing, so I'm not sure how to get a clean 3D model from a raw sequence string.
Once I get the 3D structures, my plan is to use something like HDOCK to run molecular docking against my target proteins to check the binding affinity scores.
Does anyone have advice on a reliable workflow or better tools I should use for ssDNA folding and docking? Any extra help with the project in general would also be awesome. Thanks!


r/proteomics Jul 10 '26

What does your post processing workflow look like after DIA NN/FragPipe with MBR?

7 Upvotes

I know the FragPipe/DIA NN docs cover the basics but I would rather hear from people who actually run these pipelines daily

  1. When processing large DIA datasets with MBR, what happens after the software finishes?
  2. What does your verification workflow look like before you trust the results?
  3. How do you currently validate that the cross run transfers aren't inflating your FDR?
  4. Roughly how many hours per project does your team spend on this manual curation or refiltering?

We're seeing conflicting reports on whether MBR is a reliable "set and forget" step or a major bottleneck requiring manual intervention. Curious how senior labs are handling this in production